Upstream Processing

Considerations for US Fetal Bovine Serum Sourcing

Extensive work has greatly expanded the possibilities for fetal bovine serum sourcing.

Addressing the Training Gap for Single-Use Technologies

Workforce training is crucial for biopharmaceutical manufacturing.

Cell Culture Processing Continually Advances

Automation and digitalization technologies push cell culture bioprocessing forward.

Large-Scale Single-Use Bioreactors Can Maximize Long-Term Scale Up

April 02, 2022

The growing demand for antibody and other bio-therapeutics will require long-term scale-up solutions.

Demonstrating a Fully Continuous Bioprocess

March 03, 2022

Flexible and efficient methods are needed for biopharmaceutical manufacturing.

Outlining Cell Lines’ Future with Engineering Approaches

March 02, 2022

The use of bioengineering offers practical tools for the evolution of host cells.

Using Modeling to Improve Data Analytics for Upstream Bioprocessing Workflows

February 09, 2022

Recent trends in data analytics highlight the use of modeling techniques to improve process control and monitoring in biopharmaceutical production.

Cell Culture Processing Continually Advances

February 02, 2022

The growing use of automation and digitalization technologies push cell culture bioprocessing forward.

Recent Trends in Data Analytics for Upstream Process Workflows

January 02, 2022

Modeling techniques can improve process control and monitoring in biopharmaceutical production.

Automating Upstream Processes Helps Sync Workflows

January 02, 2022

Upstream processing is better optimized with the help of automated workflows.

FUJIFILM Irvine Scientific Opens New European Manufacturing Facility

December 16, 2021

FUJIFILM Irvine Scientific’s new manufacturing facility in Tilburg, the Netherlands, is now fully operational.

Sartorius Launches Expansion in South Korea with Mullti-Million Dollar Investment

December 02, 2021

Sartorius will invest approximately €270 million (US$305 million) to expand its biopharmaceutical manufacturing activities in South Korea’s biopharm hub.

Lonza Invests in Microbial Development Lab Expansion

November 18, 2021

Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.